GlassScriptPhysician profile
Chao Hung Kao
NPI 1629303698
$5,655.67
in general payments reported to CMS, 2019-2025
36 companies · $822 in 2025
The $822 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $922 · 2022: $1,005 · 2023: $1,642 · 2024: $1,265 · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,611 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,611.10 |
| Education | $117.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $638.58 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $635.41 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $418.77 | 2021-2025 | |
| Lilly USA, LLC | $385.78 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $303.96 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Merck Sharp & Dohme LLC | $301.32 | 2021-2024 | Verquvo, Belsomra, Vaxneuvance |
| Amgen INC. | $263.49 | 2023-2025 | Evenity, Prolia, Repatha |
| Janssen Pharmaceuticals, INC | $249.97 | 2021-2022 | |
| Glaxosmithkline, LLC. | $230.11 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $204.92 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $199.38 | 2021 | |
| Radius Health, INC. | $183.53 | 2022-2025 | Tymlos |
| Genzyme Corporation | $174.39 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.62 | 2022-2025 | Jardiance, Synjardy |
| Regeneron Healthcare Solutions, INC. | $153.65 | 2023-2024 | Dupixent |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chao Hung Kao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.